Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2012Journal of Clinical OncologyOpen Access

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlison J. MoskowitzMemorial Sloan Kettering Cancer CenterPHPaul A. HamlinMemorial Sloan Kettering Cancer CenterMPMiguel‐Angel PeralesnLIGHT (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moskowitz et al. (2012) studied this question.

synapsesocial.com/papers/6a7068f126a7f98052dce9bfhttps://doi.org/10.1200/jco.2012.45.3308
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Revised Response Criteria for Malignant Lymphoma2007 · 4,466 citations
  2. 2Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression2003 · 32 citations
  3. 3Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial2003 · 487 citations